DK0669980T3 - Fremgangsmåde til kontrol af polypeptidproduktion i bakterier - Google Patents
Fremgangsmåde til kontrol af polypeptidproduktion i bakterierInfo
- Publication number
- DK0669980T3 DK0669980T3 DK94901629T DK94901629T DK0669980T3 DK 0669980 T3 DK0669980 T3 DK 0669980T3 DK 94901629 T DK94901629 T DK 94901629T DK 94901629 T DK94901629 T DK 94901629T DK 0669980 T3 DK0669980 T3 DK 0669980T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- polypeptide
- phosphate
- psts
- promoter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/989,845 US5304472A (en) | 1992-11-20 | 1992-11-20 | Method of controlling polypeptide production in bacterial cells |
| PCT/US1993/011298 WO1994012636A1 (en) | 1992-11-20 | 1993-11-19 | Method of controlling polypeptide production in bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0669980T3 true DK0669980T3 (da) | 2003-11-24 |
Family
ID=25535525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94901629T DK0669980T3 (da) | 1992-11-20 | 1993-11-19 | Fremgangsmåde til kontrol af polypeptidproduktion i bakterier |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5304472A (da) |
| EP (1) | EP0669980B1 (da) |
| JP (1) | JP3503705B2 (da) |
| AT (1) | ATE247167T1 (da) |
| AU (1) | AU671512B2 (da) |
| CA (1) | CA2145388C (da) |
| DE (1) | DE69333145T2 (da) |
| DK (1) | DK0669980T3 (da) |
| ES (1) | ES2204911T3 (da) |
| IL (1) | IL107564A (da) |
| PT (1) | PT669980E (da) |
| WO (1) | WO1994012636A1 (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789199A (en) * | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US6140305A (en) | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
| AU2660397A (en) * | 1996-04-05 | 1997-10-29 | Board Of Regents, The University Of Texas System | Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells |
| ATE386126T1 (de) * | 1996-11-08 | 2008-03-15 | Neose Technologies Inc | Verbesserte expressionsvektoren |
| US6083715A (en) * | 1997-06-09 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| WO2000039304A2 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| EP1980617A1 (en) | 1998-12-31 | 2008-10-15 | Novartis Vaccines and Diagnostics, Inc. | Improved expression of HIV polypeptides and production of virus-like particles |
| AU2596600A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Modified hiv env polypeptides |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| DE10012283A1 (de) * | 2000-03-14 | 2001-09-20 | Thomas Schweder | Wirts-Vektor-Systeme zur phosphatregulierten Überproduktion von Polypeptiden in Becillus |
| US20030198621A1 (en) * | 2001-07-05 | 2003-10-23 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| CA2452015C (en) | 2001-07-05 | 2012-07-03 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| DK1412513T3 (da) | 2001-07-30 | 2010-07-12 | Genencor Int | Phosphatbegrænset inducerbar promotor og Bacillus-ekspressiongssystem |
| EP1427806A4 (en) * | 2001-08-31 | 2006-04-26 | Chiron Corp | ANTIGENIC HIV-TYPE B POLYPEPTIDE-CODING POLYNUCLEOTIDES, POLYPEPTIDES, AND USES THEREOF |
| US20030170614A1 (en) * | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| PL206286B1 (pl) * | 2001-09-13 | 2010-07-30 | Genentech Incgenentech Inc | Komórka Gram-ujemnej bakterii, sposób wytwarzania heterologicznego peptydu, sposób zapobiegania odcinaniu N-końcowego aminokwasu, sposób odcinania N-końcowego aminokwasu i sposób wytwarzania skróconego polipeptydu |
| GB0224082D0 (en) * | 2002-10-16 | 2002-11-27 | Celltech R&D Ltd | Biological products |
| WO2004081033A2 (en) * | 2003-03-11 | 2004-09-23 | National Institutes Of Health | Synthesis of proteins by cell-free protein expression |
| ES2527291T3 (es) | 2004-03-11 | 2015-01-22 | Genentech, Inc. | Proceso para la producción de polipéptidos |
| AU2012203817B2 (en) * | 2004-03-11 | 2015-05-28 | Genentech, Inc. | Process for producing polypeptides |
| KR20070100307A (ko) | 2004-12-22 | 2007-10-10 | 제넨테크, 인크. | 가용성 다중 막관통 단백질의 생산 방법 |
| US20080032343A1 (en) | 2005-12-22 | 2008-02-07 | Genentech, Inc. | Recombinant Production of Heparin Binding Proteins |
| JP2010500417A (ja) * | 2006-08-11 | 2010-01-07 | ライフ テクノロジーズ コーポレーション | センサータンパク質及びアッセイ方法 |
| GB201000591D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000587D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial hoist strain |
| GB201000588D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| GB201000590D0 (en) | 2010-01-14 | 2010-03-03 | Ucb Pharma Sa | Bacterial host strain |
| EP2546267A1 (en) | 2011-07-13 | 2013-01-16 | UCB Pharma S.A. | Bacterial host strain expressing recombinant DsbC |
| HUE035674T2 (en) | 2011-07-13 | 2018-05-28 | Ucb Biopharma Sprl | Bacterial host strain expressing recombinant dsbc |
| GB201208367D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Biological product |
| EP2970869A4 (en) * | 2013-03-14 | 2016-08-03 | Codexis Inc | REPRESSIBLE PROMOTER WITH LOW PHOSPHATE CONTENT |
| KR102185850B1 (ko) * | 2020-02-21 | 2020-12-02 | 씨제이제일제당 주식회사 | 퓨린 뉴클레오티드를 생산하는 미생물 및 이를 이용한 퓨린 뉴클레오티드의 생산방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS592689A (ja) * | 1982-06-04 | 1984-01-09 | Handai Biseibutsubiyou Kenkyukai | 強力な遺伝子発現能を有する新規レプリコンの作成法 |
| FR2575760A1 (fr) * | 1985-01-04 | 1986-07-11 | Merieux Inst | Nouvelles souches d'escherichia coli excretrices de phosphatase alcaline, procede d'obtention de ces souches, procede de production de phosphatase alcaline et de proteines hybrides derivees |
| JPS61280292A (ja) * | 1985-06-04 | 1986-12-10 | Wakunaga Pharmaceut Co Ltd | 菌体外分泌による蛋白質の製造法 |
| FR2599380A1 (fr) * | 1986-05-29 | 1987-12-04 | Centre Nat Rech Scient | Vecteur d'exportation de proteines chez escherichiacoli, bacteries transformees et procede pour la preparation de proteines |
| FR2606031A1 (fr) * | 1986-11-03 | 1988-05-06 | Merieux Inst | Nouvelles souches d'escherichia coli hyperproductrices et/ou hyperexcretrices de proteines exportees, procede d'obtention de ces souches, et application a la production de proteines |
| EP0441252B1 (en) * | 1990-02-07 | 1997-09-03 | Abbott Laboratories | Alkaline phosphatase enzymes having improved specific activity for use in indicator reagents |
-
1992
- 1992-11-20 US US07/989,845 patent/US5304472A/en not_active Expired - Lifetime
-
1993
- 1993-11-10 IL IL10756493A patent/IL107564A/xx not_active IP Right Cessation
- 1993-11-19 PT PT94901629T patent/PT669980E/pt unknown
- 1993-11-19 AU AU56151/94A patent/AU671512B2/en not_active Ceased
- 1993-11-19 WO PCT/US1993/011298 patent/WO1994012636A1/en not_active Ceased
- 1993-11-19 JP JP51329494A patent/JP3503705B2/ja not_active Expired - Fee Related
- 1993-11-19 DK DK94901629T patent/DK0669980T3/da active
- 1993-11-19 EP EP94901629A patent/EP0669980B1/en not_active Expired - Lifetime
- 1993-11-19 CA CA002145388A patent/CA2145388C/en not_active Expired - Fee Related
- 1993-11-19 DE DE69333145T patent/DE69333145T2/de not_active Expired - Lifetime
- 1993-11-19 AT AT94901629T patent/ATE247167T1/de active
- 1993-11-19 ES ES94901629T patent/ES2204911T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69333145T2 (de) | 2004-06-17 |
| AU5615194A (en) | 1994-06-22 |
| CA2145388A1 (en) | 1994-06-09 |
| WO1994012636A1 (en) | 1994-06-09 |
| ES2204911T3 (es) | 2004-05-01 |
| CA2145388C (en) | 2004-08-10 |
| US5304472A (en) | 1994-04-19 |
| IL107564A (en) | 2000-08-31 |
| ATE247167T1 (de) | 2003-08-15 |
| EP0669980A1 (en) | 1995-09-06 |
| EP0669980B1 (en) | 2003-08-13 |
| DE69333145D1 (de) | 2003-09-18 |
| JP3503705B2 (ja) | 2004-03-08 |
| IL107564A0 (en) | 1994-02-27 |
| JPH08503612A (ja) | 1996-04-23 |
| PT669980E (pt) | 2003-12-31 |
| AU671512B2 (en) | 1996-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL107564A0 (en) | Method of controlling polypeptide production in bacteria | |
| ES8700320A1 (es) | Metodo de obtencion del exprimido de una materia seleccionada que contiene renina. | |
| DK0691405T3 (da) | Materialer og fremgangsmåde til hypersecernering af aminosyrer | |
| CA2080920A1 (en) | Cloning by complementation and related processes | |
| FI915810A0 (fi) | Foerfarande foer doedande av celler utan soenderdelning av cellerna. | |
| ATE246251T1 (de) | Verfahren zur herstellung von polypeptiden in surfaktinmutanten von bacillus zellen | |
| BR8205954A (pt) | Sequencia de dna,plasmidio recombinante,cultura bacteriana e microorganismos | |
| AU588793B2 (en) | Method of expressing alpha-1-antitrypsin in bacteria | |
| AU7126487A (en) | Production of proteins by cell culture | |
| DK0698667T3 (da) | Xylanase, mikroorganismer til produktion deraf, DNA-molekyler, fremgangsmåder til fremstilling af denne xylanase og anvendelser deraf | |
| DE69916892D1 (de) | Verfahren zur isolierung von ccc plasmid dna | |
| FI964208A0 (fi) | Menetelmä metallofosfaatin saostumisen kontrolloimiseksi fermentoinneissa, joissa solutiheys on suuri | |
| DE69941789D1 (de) | In vivo-verfahren zur herstellung von proteinen, die nicht-konventionelle aminosäuren enthalten | |
| ATE161880T1 (de) | Biokontrolle von mikrobiellen pathogenen | |
| ATE152176T1 (de) | Verfahren zum regeln des norleucingehalts in polypeptiden | |
| DE69021005D1 (de) | Verfahren zur Kultur von Tomaten-Protoplasten. | |
| ATE288476T1 (de) | Herstellung von proteinen | |
| WO2002064811A3 (fr) | Procede pour produire des proteines recombinantes, marquees par au moins un isotope | |
| DE58909205D1 (de) | Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten. | |
| IT1258351B (it) | Nuovi costrutti di dna modulati dalla temperatura per la produzione controllata di proteine ricombinati, microorganismi modificati che li contengono e procedimenti che usano questi microorganismi. |